Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/EBITDA
-155.45 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical Inc's enterprise value is $13,729.4 Mil. Biomarin Pharmaceutical Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $-88.3 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/EBITDA ratio for today is -155.45.

BMRN' s EV/EBITDA Range Over the Past 10 Years
Min: -25504   Max: 1532.3
Current: -150.12

-25504
1532.3

During the past 13 years, the highest EV/EBITDA Ratio of Biomarin Pharmaceutical Inc was 1532.30. The lowest was -25504.00. And the median was -73.80.

BMRN's EV/EBITDA is ranked lower than
99.99% of the 276 Companies
in the Global Biotechnology industry.

( Industry Median: 20.97 vs. BMRN: -150.12 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Biomarin Pharmaceutical Inc's stock price is $80.74. Biomarin Pharmaceutical Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $-1.21. Therefore, Biomarin Pharmaceutical Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Biomarin Pharmaceutical Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=13729.375/-88.323
=-155.45

Biomarin Pharmaceutical Inc's current Enterprise Value is $13,729.4 Mil.
Biomarin Pharmaceutical Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was -53.78 (Jun. 2015 ) + -72.433 (Sep. 2015 ) + 96.929 (Dec. 2015 ) + -59.039 (Mar. 2016 ) = $-88.3 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=80.74/-1.214
=

Biomarin Pharmaceutical Inc's share price for today is $80.74.
Biomarin Pharmaceutical Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was -0.51 (Jun. 2015 ) + -0.6 (Sep. 2015 ) + 0.426 (Dec. 2015 ) + -0.53 (Mar. 2016 ) = $-1.21.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -101.90-326.1726.4558.82180.64-23,974.95-94.71-81.24-219.12-202.90

Biomarin Pharmaceutical Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda -81.24-87.25-81.97-207.79-219.12-208.36-153.52-72.31-202.90-153.29
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK